Patent Law Weblog
recent posts
- Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc. (2026)
- Constellation Designs, LLC v. LG Electronics Inc. (Fed. Cir. 2026)
- Actelion Pharmaceuticals Ltd. v. Mylan Pharmaceuticals Inc. (Fed. Cir. 2026)
- PTAB Reverses § 101 Rejection Where Examiner Failed to Follow the Office’s Own Guidance
- Collision Communications v. Samsung: What Good Did the Government’s Statement of Interest Do?
about
Month: January 2009
-
By Jason Derry —ZymoGenetics Licenses Ex-North American Rights to IL-21 ZymoGenetics, Inc. has announced that it has licensed the rights to development and commercialization of interleukin 21 (IL-21) outside North America from Novo Nordisk A/S. The agreement means that the Seattle-based biotech company now has worldwide rights to IL-21. ZymoGenetics has indicated that it…
-
American Conference Institute (ACI) will be holding the next session of its FDA Boot Camp conference on March 30-31, 2009 in New York, NY. The conference will allow attendees to: • Master the basics of the application and approval processes for drugs, biologics, and devices;• Comprehend the structure of the FDA and the roles of…
-
Practising Law Institute (PLI) will be offering an audio webcast entitled: "Stanford IP Litigation Clearinghouse: A Pioneering Database with 'Life and Death' Statistics for Patent Litigators" on February 12, 2009 from 1:00-2:00 PM (EST). Professor Mark Lemley of Stanford Law School; Matthew Lynde of Cornerstone Research; and Joshua Walker, Executive Director of the IP Litigation…
-
FX Conferences will be offering an audio conference entitled "Patent Portfolio Strategies in the Post-KSR Environment" on February 12, 2009 from 11:30 AM to 12:30 PM (EST). Bruce Sunstein of Bromberg & Sunstein LLP will examine how the Supreme Court’s decision in KSR Int'l Co. v. Teleflex, Inc. changes the landscape for biopharma companies and…
-
The ABA Center for Continuing Legal Education will be offering a webcast entitled: "Compulsory Licensing and Other IP Controls" on February 14, 2009 from 7:30-9:00 AM (CST). William Fisher, Professor of Intellectual Property Law at Harvard University; Ronald Cass of Cass & Associates; Greg Slater of Intel Corp., and Yee Wah Chin of Ingram Yuzek…
-
By Kevin E. Noonan — The Supreme Court was petitioned today to grant certiorari in two cases important to biotechnology patenting: In re Bilski, involving the standard for determining that method claims are patentable subject matter; and Aventis Pharma S.A. v. Amphastar Pharmaceuticals, regarding the standard for finding inequitable conduct. And in each case,…
-
By Donald Zuhn — On Monday, Neuralstem, Inc. announced that the U.S. Patent and Trademark Office allowed U.S. Application No. 10/047,352 (U.S. Patent Publication No. 2002/0064873), entitled "Stable neural stem cell lines." The '352 application, which was allowed on January 13th, is directed to a method for establishing stable neural stem cell lines and…
-
By Donald Zuhn — Earlier this month, Science Progress, a semi-annual journal published by the Center for American Progress, issued a series of reports on the U.S. patent system. The series, outlined in an article entitled: "Patent Reform 101," consists of four reports: • "Tackling the Challenge of Patent Reform: Recommendations for the Obama…
-
By Christopher P. Singer — In a January 28, 2008 press release, the U.S. Patent and Trademark Office announced that the existing pilot Patent Prosecution Highway (PPH) program with the Korean Intellectual Property Office (KIPO) will expire in favor of a permanent PPH which begins on January 29, 2009. Applicants who participate in the…
-
By Kevin E. Noonan — Intellectual property rights (particularly Western intellectual property rights) were intended to receive improved protection under the Trade-related Aspects of Intellectual Property Rights (TRIPS) provisions of the General Agreement on Tariffs and Trade (GATT). The World Trade Organization (WTO) was to provide the forum for disputes arising under TRIPS. However,…
Patent Docs 